India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Metformin: An important drug for controlling diabetes If type-2 diabetes is not controlled, there is only one option. That is taking medicine. If the question is asked about what kind of medicine should be taken in diabetes, the list becomes very long. Among them, if we had to name a medicine that should be taken daily, the name that hangs on the lips of people with diabetes is metformin. Metformin is a drug used in the treatment of diabetes. This medicine may need to be taken continuously after the blood sugar level in the body increases. And, if not treated, diabetes can become uncontrolled and affect the body's organs like kidneys and heart, and there is a risk of death. Therefore, metformin is considered as an essential medicine for those with type 2 diabetes. In type one (hereditary) diabetes, diabetes can only be controlled if insulin (a drug that controls the body's glucose through a needle) is given. How does metformin work in the body? Metformin does not allow the blo...